News | Heart Valve Technology | January 15, 2019

Boston Scientific, Edwards Lifesciences Agree To Global Litigation Settlement

All patent litigation between the companies to be dismissed

Boston Scientific, Edwards Lifesciences Agree To Global Litigation Settlement

January 15, 2019 — Boston Scientific Corp. and Edwards Lifesciences Corp. announced that the companies have reached an agreement to settle all outstanding patent disputes between the companies in all venues around the world. All pending cases or appeals in courts and patent offices between the two companies will be dismissed, and the parties will not litigate patent disputes related to current portfolios of transcatheter aortic valves, certain mitral valve repair devices and left atrial appendage closure devices. Any injunctions currently in place will be lifted.

Under the terms of the agreement, Edwards has made a one-time payment to Boston Scientific of $180 million. No further royalties will be owed by either party under the agreement. All other terms remain confidential.

On Dec. 11, a jury in the U.S. District Court for the District of Delaware determined that the Boston Scientific U.S. patent 8,992,608 is valid and that Edwards Lifesciences’ Sapien 3 aortic valve infringes this patent. The court ruled at that time that Edwards owed Boston Scientific $35 million in infringement damages through the end of 2016. The jury also found that the Boston Scientific Lotus aortic valve system does not infringe Edwards’ Spenser patents U.S. 7,510,575, U.S. 9,168,133, or U.S. 9,339,383.

Read the article Boston Scientific Prevails in U.S. Edwards Lifesciences Litigation

For more information: www.bostonscientific.com, www.edwards.com


Additional Content

News | Cath Lab

Nov. 2, 2026 — Royal Philips has announced U.S. commercial availability of the HyperVue Integrated System1, a new single ...

Home November 03, 2026
Home
News | Cath Lab

Aug. 28, 2026 — Heartflow, Inc. has announced late-breaking one-year results from an independent randomized clinical ...

Home August 28, 2026
Home
News | Cath Lab

July 9, 2026 — On July 9, Stereotaxis announced that it has completed its previously announced acquisition of Robocath ...

Home July 10, 2026
Home
News | Cath Lab

June 18, 2026 — Allegheny Health Network's (AHN) Allegheny General Hospital (AGH) has completed a $19 million renovation ...

Home June 18, 2026
Home
News | Cath Lab

May 28, 2026 — RWJBarnabas Health has earned Cardiac Catheterization Lab Accreditation from the American College of ...

Home May 29, 2026
Home
Subscribe Now